Clinical Trial Update: GLP-1/Basal Insulin Combination Therapy

View source ↗

Summary

A completed clinical trial evaluating a combination therapy of a GLP-1 receptor agonist with basal insulin for Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal insulin (basal insulin)
• GLP-1 receptor agonist

Snippet

Sponsor: Albany College of Pharmacy and Health Sciences | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED